Medytox Inc., 10% Owner at Evolus, Inc. (EOLS), sold 26,000 shares at $13.28 ($345K) on 2022-08-01, disclosed to the SEC on 2022-08-03.
Open-market sale of $345k EOLS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EOLS | SELL | 2023-02-06 | $818K | — | Filing → |
| EOLS | BUY | 2023-02-06 | $565K | — | Filing → |
| EOLS | SELL | 2022-10-07 | $689K | — | Filing → |